SUPRATENTORIAL GLIOSARCOMA
Clinical trials for SUPRATENTORIAL GLIOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new SUPRATENTORIAL GLIOSARCOMA trials appear
Sign up with your email to follow new studies for SUPRATENTORIAL GLIOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Genetically modified immune cells take on deadly brain tumors
Disease control Recruiting nowThis early-stage trial tests genetically engineered natural killer (NK) cells in 25 people with recurrent glioblastoma, an aggressive brain cancer. The cells are designed to resist the tumor's defenses. The main goal is to find a safe dose and check for side effects, while also w…
Matched conditions: SUPRATENTORIAL GLIOSARCOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Gene-Edited stem cells may let doctors use stronger chemo against brain cancer
Disease control Recruiting nowThis study tests a new approach for people with a recently removed glioblastoma (a fast-growing brain tumor). Doctors take some of the patient's own blood stem cells, add a protective gene (P140K MGMT) to them, and return them to the patient. This allows the use of higher doses o…
Matched conditions: SUPRATENTORIAL GLIOSARCOMA
Phase: PHASE2 • Sponsor: Leland Metheny • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC